Regentatlantic Capital LLC boosted its stake in shares of Express Scripts Holding Company (NASDAQ:ESRX) by 9.8% during the second quarter, Holdings Channel reports. The institutional investor owned 44,542 shares of the company’s stock after buying an additional 3,991 shares during the period. Regentatlantic Capital LLC’s holdings in Express Scripts Holding were worth $2,844,000 at the end of the most recent quarter.
A number of other institutional investors have also recently added to or reduced their stakes in ESRX. Dubuque Bank & Trust Co. raised its position in Express Scripts Holding by 53.1% in the first quarter. Dubuque Bank & Trust Co. now owns 1,753 shares of the company’s stock valued at $116,000 after buying an additional 608 shares in the last quarter. TrimTabs Asset Management LLC purchased a new position in Express Scripts Holding during the first quarter valued at approximately $121,000. Capital Analysts LLC raised its position in Express Scripts Holding by 5.6% in the first quarter. Capital Analysts LLC now owns 1,877 shares of the company’s stock valued at $124,000 after buying an additional 100 shares in the last quarter. IHT Wealth Management LLC raised its position in Express Scripts Holding by 8.1% in the first quarter. IHT Wealth Management LLC now owns 1,944 shares of the company’s stock valued at $128,000 after buying an additional 145 shares in the last quarter. Finally, FNY Partners Fund LP purchased a new position in Express Scripts Holding during the first quarter valued at approximately $138,000. 90.20% of the stock is currently owned by hedge funds and other institutional investors.
Shares of Express Scripts Holding Company (ESRX) traded down 1.1600% on Thursday, hitting $60.4901. 2,015,447 shares of the stock were exchanged. The company has a market cap of $34.94 billion, a price-to-earnings ratio of 10.4981 and a beta of 0.90. The company has a 50 day moving average of $62.96 and a 200 day moving average of $64.58. Express Scripts Holding Company has a 52-week low of $57.80 and a 52-week high of $77.61.
Express Scripts Holding (NASDAQ:ESRX) last released its quarterly earnings data on Tuesday, July 25th. The company reported $1.73 earnings per share for the quarter, beating analysts’ consensus estimates of $1.71 by $0.02. The firm had revenue of $25.35 billion during the quarter, compared to analyst estimates of $25.52 billion. Express Scripts Holding had a return on equity of 25.58% and a net margin of 3.50%. The business’s quarterly revenue was up .5% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.57 earnings per share. Equities research analysts forecast that Express Scripts Holding Company will post $6.99 earnings per share for the current year.
COPYRIGHT VIOLATION NOTICE: This piece was first reported by Ticker Report and is the sole property of of Ticker Report. If you are viewing this piece on another site, it was illegally stolen and reposted in violation of U.S. & international trademark & copyright laws. The legal version of this piece can be viewed at https://www.tickerreport.com/banking-finance/2800597/express-scripts-holding-company-esrx-position-increased-by-regentatlantic-capital-llc.html.
ESRX has been the topic of several recent analyst reports. SunTrust Banks, Inc. reissued a “buy” rating on shares of Express Scripts Holding in a report on Tuesday, April 25th. Jefferies Group LLC set a $88.00 target price on shares of Express Scripts Holding and gave the company a “buy” rating in a report on Thursday, April 20th. UBS AG set a $71.00 target price on shares of Express Scripts Holding and gave the company a “hold” rating in a report on Tuesday, April 25th. Edward Jones lowered shares of Express Scripts Holding from a “buy” rating to a “hold” rating in a report on Wednesday, April 26th. Finally, BidaskClub raised shares of Express Scripts Holding from a “sell” rating to a “hold” rating in a report on Saturday, June 17th. Four investment analysts have rated the stock with a sell rating, thirteen have given a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company’s stock. Express Scripts Holding presently has a consensus rating of “Hold” and a consensus price target of $70.81.
In other news, VP Phyllis S. Anderson sold 1,100 shares of the stock in a transaction that occurred on Friday, May 19th. The stock was sold at an average price of $60.08, for a total transaction of $66,088.00. Following the completion of the sale, the vice president now owns 11,108 shares of the company’s stock, valued at $667,368.64. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Corporate insiders own 0.68% of the company’s stock.
Express Scripts Holding Company Profile
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding Company (NASDAQ:ESRX).
Receive News & Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related companies with MarketBeat.com's FREE daily email newsletter.